Literature DB >> 10889332

Synthesis and antitubercular activity of 3-aryl substituted-2-[1H(2H)benzotriazol-1(2)-yl]acrylonitriles.

P Sanna1, A Carta, M E Nikookar.   

Abstract

A series of 22 3-aryl substituted-2-(1H(2H)-benzotriazol-1(2)-yl)acrylonitriles was synthesized for a preliminary in vitro evaluation of antitubercular activity according to an international program with the Tuberculosis Antimicrobial Acquisition & Coordinating Facility (TAACF). This work reports the synthetic approach and analytical and spectroscopic characterization (UV, IR, 1H- and 13C-NMR) of all compounds synthesized. Several compounds showed an interesting activity in the preliminary screening with a percent growth inhibition of the virulent Mycobacterium tuberculosis between 40 and 99% at the concentration of 12.5 microg/mL. The most effective derivatives E-5a and E-5e were also tested against M. avium in vitro.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10889332     DOI: 10.1016/s0223-5234(00)00144-6

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  10 in total

1.  Synthesis of substituted stilbenes via the Knoevenagel condensation.

Authors:  Shar Saad Al-Shihry
Journal:  Molecules       Date:  2004-07-31       Impact factor: 4.411

2.  High throughput screening of a library based on kinase inhibitor scaffolds against Mycobacterium tuberculosis H37Rv.

Authors:  Robert C Reynolds; Subramaniam Ananthan; Ellen Faaleolea; Judith V Hobrath; Cecil D Kwong; Clinton Maddox; Lynn Rasmussen; Melinda I Sosa; Elizabeth Thammasuvimol; E Lucile White; Wei Zhang; John A Secrist
Journal:  Tuberculosis (Edinb)       Date:  2011-06-25       Impact factor: 3.131

3.  Exploration of NMI-MsCl mediated amide bond formation for the synthesis of novel 3,5-substituted-1,2,4-oxadiazole derivatives: synthesis, evaluation of anti-inflammatory activity and molecular docking studies.

Authors:  B Kulkarni; K Manjunatha; Muthipeedika Nibin Joy; Ayyiliath Meleveetil Sajith; Sougata Santra; Grigory V Zyryanov; C N Prashantha; Mohammed B Alshammari; K Sunil
Journal:  Mol Divers       Date:  2022-10-11       Impact factor: 3.364

4.  Design, synthesis and molecular docking studies of some 1-(5-(2-fluoro-5-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-3-yl)piperazine derivatives as potential anti-inflammatory agents.

Authors:  B Kulkarni; K Manjunatha; Muthipeedika Nibin Joy; Ayyiliath Meleveetil Sajith; C N Prashantha; Ranjith Pakkath; Mohammed B Alshammari
Journal:  Mol Divers       Date:  2021-11-24       Impact factor: 3.364

5.  The impact of acrylonitrile and bioaugmentation on the biodegradation activity and bacterial community structure of a topsoil.

Authors:  J Baxter; N J Garton; S P Cummings
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

6.  Modular synthesis of N-vinyl benzotriazoles.

Authors:  Govindra Singh; Rakesh Kumar; Jorge Swett; Barbara Zajc
Journal:  Org Lett       Date:  2013-08-05       Impact factor: 6.005

7.  (Z)-3-(1-Benzofuran-2-yl)-2-(3,4,5-tri-meth-oxy-phen-yl)acrylonitrile.

Authors:  Narsimha Reddy Penthala; Sean Parkin; Peter A Crooks
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-02-17

Review 8.  Benzotriazole: An overview on its versatile biological behavior.

Authors:  I Briguglio; S Piras; P Corona; E Gavini; M Nieddu; G Boatto; A Carta
Journal:  Eur J Med Chem       Date:  2014-09-30       Impact factor: 6.514

9.  Sulfonic acid functionalized metal-organic framework (S-IRMOF-3): a novel catalyst for sustainable approach towards the synthesis of acrylonitriles.

Authors:  Ryhan Abdullah Rather; Zeba N Siddiqui
Journal:  RSC Adv       Date:  2019-05-21       Impact factor: 4.036

10.  Design, synthesis, and biological screening of a series of 4'-fluoro-benzotriazole-acrylonitrile derivatives as microtubule-destabilising agents (MDAs).

Authors:  Federico Riu; Roberta Ibba; Stefano Zoroddu; Simona Sestito; Michele Lai; Sandra Piras; Luca Sanna; Valentina Bordoni; Luigi Bagella; Antonio Carta
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.